CoChat

Dysregulation in microRNA Expression Is Associated with Alterations in Immune Functions in Combat Veterans with Post-Traumatic Stress Disorder

Open access

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Abstract

While the immunological dysfunction in combat Veterans with post-traumatic stress disorder (PTSD) has been well documented, the precise mechanisms remain unclear. The current study evaluated the role of microRNA (miR) in immunological dysfunction associated with PTSD. The presence of peripheral blood mononuclear cells (PBMC) and various lymphocyte subsets in blood collected from PTSD patients were analyzed. Our studies demonstrated that the numbers of both PBMC and various lymphocyte subsets increased significantly in PTSD patients. When T cells were further analyzed, the percentage of Th1 cells and Th17 cells increased, regulatory T cells(Tregs) decreased, while Th2 cells remained unaltered in PTSD patients. These data correlated with increased plasma levels of IFN-γ and IL-17 while IL-4 showed no significant change. The increase in PBMC counts, Th1 and Th17 cells seen in PTSD patients correlated with the clinical scores. High-throughput analysis of PBMCs for 1163 miRs showed that the expression of a significant number of miRs was altered in PTSD patients. Pathway analysis of dysregulated miRs seen in PTSD patients revealed relationship between selected miRNAs and genes that showed direct/indirect role in immunological signaling pathways consistent with the immunological changes seen in these patients. Of interest was the down-regulation of miR-125a in PTSD, which specifically targeted IFN-γ production. Together, the current study demonstrates for the first time that PTSD was associated with significant alterations in miRNAs, which may promote pro-inflammatory cytokine profile. Such epigenetic events may provide useful tools to identify potential biomarkers for diagnosis, and facilitate therapy of PTSD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0094075

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 PBMC counts and correlation between clinical scores. The PTSD scores, anxiety scores and depression scores were used to determine the disease severity in PTSD patients. The higher score represented the more severe PTSD disease. PBMC were isolated from peripheral blood samples of patients with PTSD and healthy controls by Ficoll gradient centrifugation and viable cells were enumerated. Wilcoxon rank sum test was used to compare the difference of PBMC counts between controls and PTSD patients (A). Spearman rank correlation was used to analyze the correlation between anxiety scores and PBMC counts (B), between PTSD scores and anxiety scores (C), between PTSD scores and depression scores (D) and between anxiety scores and depression scores (E) in PTSD patients. Each dot or diamond symbol represents data from an individual patient or normal control. In panel A, the boxed data included 50% of measurements at medium level, the line in the box was the average value and the data beyond the upper line were the outliers. In panels B–E, both correlation coefficient (R) and p values were presented.
Figure 1 PBMC counts and correlation between clinical scores. The PTSD scores, anxiety scores and depression scores were used to determine the disease severity in PTSD patients. The higher score represented the more severe PTSD disease. PBMC were isolated from peripheral blood samples of patients with PTSD and healthy controls by Ficoll gradient centrifugation and viable cells were enumerated. Wilcoxon rank sum test was used to compare the difference of PBMC counts between controls and PTSD patients (A). Spearman rank correlation was used to analyze the correlation between anxiety scores and PBMC counts (B), between PTSD scores and anxiety scores (C), between PTSD scores and depression scores (D) and between anxiety scores and depression scores (E) in PTSD patients. Each dot or diamond symbol represents data from an individual patient or normal control. In panel A, the boxed data included 50% of measurements at medium level, the line in the box was the average value and the data beyond the upper line were the outliers. In panels B–E, both correlation coefficient (R) and p values were presented.CC0 · PubMed Central
Figure 2 Comparison of cell populations in PBMC between controls and PTSD patients. PBMC were isolated from peripheral blood samples of patients with PTSD and normal controls as described in Fig. 1. After staining with FITC-anti-CD3, PE-anti-CD8 and APC-anti-CD4 antibodies, CD4 and CD8 T cells were analyzed by flow cytometry. After staining with FITC-anti-CD19 and APC-anti-CD3 antibodies, B cells (CD19+) were analyzed by flow cytometry. After staining with PE-anti-CD56 and APC-anti-CD3 antibodies, NK (CD56+) and NKT cells (CD56+CD3+) were analyzed by flow cytometry. The difference in the percentages of various lymphocyte subsets in PBMC between normal controls and PTSD patients was shown (A). The differences in absolute numbers of CD4 T cells (B), CD8 T cells (C), B cells (D), NK cells (E) and NKT cells (F) in PBMC between individual controls and PTSD patients were also presented. Wilcoxon rank sum test was used to compare the difference between controls and PTSD patients. In panels B–F, the boxed data included 50% of measurements at medium level, the line in the box was the average value and the data beyond the upper line were the outliers. p values were also presented.
Figure 2 Comparison of cell populations in PBMC between controls and PTSD patients. PBMC were isolated from peripheral blood samples of patients with PTSD and normal controls as described in Fig. 1. After staining with FITC-anti-CD3, PE-anti-CD8 and APC-anti-CD4 antibodies, CD4 and CD8 T cells were analyzed by flow cytometry. After staining with FITC-anti-CD19 and APC-anti-CD3 antibodies, B cells (CD19+) were analyzed by flow cytometry. After staining with PE-anti-CD56 and APC-anti-CD3 antibodies, NK (CD56+) and NKT cells (CD56+CD3+) were analyzed by flow cytometry. The difference in the percentages of various lymphocyte subsets in PBMC between normal controls and PTSD patients was shown (A). The differences in absolute numbers of CD4 T cells (B), CD8 T cells (C), B cells (D), NK cells (E) and NKT cells (F) in PBMC between individual controls and PTSD patients were also presented. Wilcoxon rank sum test was used to compare the difference between controls and PTSD patients. In panels B–F, the boxed data included 50% of measurements at medium level, the line in the box was the average value and the data beyond the upper line were the outliers. p values were also presented.CC0 · PubMed Central
Figure 3 Comparison of T helper cell populations in PBMC between controls and PTSD patients and correlation between T helper cell populations and PTSD scores. A–D: Comparison of T helper cell populations in PBMC between controls and PTSD patients. PBMC from PTSD and normal controls were stimulated with 50 µg/mL of PHA for 3 days. Cells were stained with FITC-anti-IFN-γ, PE-anti-IL-4 and APC-anti-CD4 antibodies, and Th1 and Th2 cell populations were analyzed by flow cytometry. After staining with FITC-anti-IL-17A, PE-anti-FoxP3 and APC-anti-CD4 antibodies, Th17 and regulatory T cell (Treg) populations were analyzed by flow cytometry. Wilcoxon rank sum test was used to compare the difference of Th1 (A), Th17 (B), Treg (C) and Th2 (D) cell populations in controls and PTSD patients. The boxed data included 50% of measurements at medium level, the line in the box was the average value and the data beyond the upper line were the outliers. p values were also presented. E–I: Correlation between T helper cell populations and clinical scores in PTSD patients. PBMC from PTSD and normal controls were stimulated with 50 µg/mL of PHA for 3 days and stained for Th1, Th2, Th17 and Tregs as described above. Spearman rank correlation was used to analyze the correlation between PTSD scores and percentages of T helper cell populations from PTSD patients. The correlation between PTSD scores and T helper/Treg populations in PTSD patients was shown by the heat map (E), and the correlation between PTSD scores and Th1 (F), Th17 (G), Treg (H) and Th2 (I) cell populations in PTSD patients was presented. In panels F–I, correlation coefficient (R) and p values were presented.
Figure 3 Comparison of T helper cell populations in PBMC between controls and PTSD patients and correlation between T helper cell populations and PTSD scores. A–D: Comparison of T helper cell populations in PBMC between controls and PTSD patients. PBMC from PTSD and normal controls were stimulated with 50 µg/mL of PHA for 3 days. Cells were stained with FITC-anti-IFN-γ, PE-anti-IL-4 and APC-anti-CD4 antibodies, and Th1 and Th2 cell populations were analyzed by flow cytometry. After staining with FITC-anti-IL-17A, PE-anti-FoxP3 and APC-anti-CD4 antibodies, Th17 and regulatory T cell (Treg) populations were analyzed by flow cytometry. Wilcoxon rank sum test was used to compare the difference of Th1 (A), Th17 (B), Treg (C) and Th2 (D) cell populations in controls and PTSD patients. The boxed data included 50% of measurements at medium level, the line in the box was the average value and the data beyond the upper line were the outliers. p values were also presented. E–I: Correlation between T helper cell populations and clinical scores in PTSD patients. PBMC from PTSD and normal controls were stimulated with 50 µg/mL of PHA for 3 days and stained for Th1, Th2, Th17 and Tregs as described above. Spearman rank correlation was used to analyze the correlation between PTSD scores and percentages of T helper cell populations from PTSD patients. The correlation between PTSD scores and T helper/Treg populations in PTSD patients was shown by the heat map (E), and the correlation between PTSD scores and Th1 (F), Th17 (G), Treg (H) and Th2 (I) cell populations in PTSD patients was presented. In panels F–I, correlation coefficient (R) and p values were presented.CC0 · PubMed Central
Figure 4 Comparison of cytokines IFN-γ, IL-17, PDGF-bb, RANTES and IL-4inplasma from controls and PTSD patients. Plasma samples were isolated from peripheral blood samples of patients with PTSD and normal controls by centrifugation. Then, Bio-Rad Bio-Plex method was used to determine the concentrations of multiple cytokines (including IL-1β, IL-1RA, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12(p70), IL-13, IL-15, IL-17, FGF-β, eotaxin, G-CSF, GM-CSF, IFN-γ, IP-10, MCP-1, MIP-1α, MIP-1β, PDGF-BB, RANTES, TNF-α and VEGF). Wilcoxon rank sum test was used to compare the difference of cytokines in the plasma between controls and PTSD patients. Plasma levels of IFN-γ (A), IL-17 (B), PDGF-bb (C), and RANTES (D) were found to be significantly different between controls and PTSD patients, whereas other cytokines such as IL-4 (E) did not have significant difference in plasma from controls and PTSD patients. The boxed data included 50% of measurements at medium level, the line in the box was the average value and the data beyond the upper line were the outliers. p values were presented.
Figure 4 Comparison of cytokines IFN-γ, IL-17, PDGF-bb, RANTES and IL-4inplasma from controls and PTSD patients. Plasma samples were isolated from peripheral blood samples of patients with PTSD and normal controls by centrifugation. Then, Bio-Rad Bio-Plex method was used to determine the concentrations of multiple cytokines (including IL-1β, IL-1RA, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12(p70), IL-13, IL-15, IL-17, FGF-β, eotaxin, G-CSF, GM-CSF, IFN-γ, IP-10, MCP-1, MIP-1α, MIP-1β, PDGF-BB, RANTES, TNF-α and VEGF). Wilcoxon rank sum test was used to compare the difference of cytokines in the plasma between controls and PTSD patients. Plasma levels of IFN-γ (A), IL-17 (B), PDGF-bb (C), and RANTES (D) were found to be significantly different between controls and PTSD patients, whereas other cytokines such as IL-4 (E) did not have significant difference in plasma from controls and PTSD patients. The boxed data included 50% of measurements at medium level, the line in the box was the average value and the data beyond the upper line were the outliers. p values were presented.CC0 · PubMed Central
Figure 5 Dysregulation in miRNA expression profile in PBMC from PTSD patients and controls. A–F: Total RNA from PBMC of patients with PTSD and normal controls were used in the analysis of miRNA expression by Affymetrix miRNA array hybridization. Comparison of miRNA expression profiles between individual controls and PTSD patients was shown by the heat map (A) and plot of the principal component analysis accounting for 60.1% variability (B). Seven up-regulated miRNAs in PBMC from PTSD patients were compared with those from controls (C). 64 down-regulated miRNA molecules (>2.5 fold change, Table 1) in PBMC from PTSD patients were detected (D). Total RNA samples were also used in the confirmation of miRNA down-regulation (miR-125a and miR-181c) in PBMC from PTSD patients by real-time PCR (E). Wilcoxon rank sum test was used to compare the difference in miRNA expression in PBMC between controls and PTSD patients. F–G: Role of hsa-miR-125a in the regulation of IFN-γ. Complementary sequences between the seed sequence of miR-125a and 3′-untranslated region (3′UTR) of IFN-γ gene were compared (F). In silico studies were used to determine the complementary sequences between the seed sequence of miR-125a and 3′UTR of IFN-γ gene. The inhibitory effect of miR-125a on IFN-γ production in PBMC was determined (G). Hsa-miR-125a precursor (pre-miR125a) and pre-scramble control (scrambled premiR) were introduced into PBMC by electroporation. After PHA stimulation for two days, IFN-γ release from PBMC was determined in the culture supernatant by ELISA. Wilcoxon rank sum test was used to analyze the inhibitory effects of miR-125a on IFN-γ production in PBMC.
Figure 5 Dysregulation in miRNA expression profile in PBMC from PTSD patients and controls. A–F: Total RNA from PBMC of patients with PTSD and normal controls were used in the analysis of miRNA expression by Affymetrix miRNA array hybridization. Comparison of miRNA expression profiles between individual controls and PTSD patients was shown by the heat map (A) and plot of the principal component analysis accounting for 60.1% variability (B). Seven up-regulated miRNAs in PBMC from PTSD patients were compared with those from controls (C). 64 down-regulated miRNA molecules (>2.5 fold change, Table 1) in PBMC from PTSD patients were detected (D). Total RNA samples were also used in the confirmation of miRNA down-regulation (miR-125a and miR-181c) in PBMC from PTSD patients by real-time PCR (E). Wilcoxon rank sum test was used to compare the difference in miRNA expression in PBMC between controls and PTSD patients. F–G: Role of hsa-miR-125a in the regulation of IFN-γ. Complementary sequences between the seed sequence of miR-125a and 3′-untranslated region (3′UTR) of IFN-γ gene were compared (F). In silico studies were used to determine the complementary sequences between the seed sequence of miR-125a and 3′UTR of IFN-γ gene. The inhibitory effect of miR-125a on IFN-γ production in PBMC was determined (G). Hsa-miR-125a precursor (pre-miR125a) and pre-scramble control (scrambled premiR) were introduced into PBMC by electroporation. After PHA stimulation for two days, IFN-γ release from PBMC was determined in the culture supernatant by ELISA. Wilcoxon rank sum test was used to analyze the inhibitory effects of miR-125a on IFN-γ production in PBMC.CC0 · PubMed Central
Figure 6 Pathway Analysis depicting a network of dysregulated miRNAs and target genes and their relationship in regulation of immune functions and pathways. A. Dysregulated miRNAs from PTSD patients were found to be involved in immunological pathways when Ingenuity Pathway Analyses were performed. The green tags represent down-regulated miRNAs and red tags up-regulated miRNAs in PBMC from PTSD patients when compared to controls. Circles represent genes, ovals are transcriptional regulators, diamonds are enzymes and triangles are kinases. Solid arrows represent direct action and dashed arrows indirect action. B. Depicts the relationship between miRNAs from PTSD patients with their target genes. First, both upregulated and downregulated miRNAs of PTSD patients were selected following Ingenuity Pathway analysis and then the relationship between miRNAs and genes were analyzed using Cytoscape software. Cytoscape analysis showed relationship between miRNAs and immunological pathways, especially between miRNAs and cytokine-associated genes (IL-1RA, IL-2, IL-2RB, IFN-γ, IL-12, IL-10, IL-17, IL-17R, TGF-β, IL-23A, etc.) playing a role in T cell development and immune functions. The larger circles represent miRNAs that are involved in regulation of a large number of genes, when compared to miRNAs represented by smaller circles. C. Shows the role of dysregulated miRNAs from PTSD patients in various immunological mechanisms and pathways. Upregulated and down-regulated miRNAs from PTSD patients were analyzed using Cytoscape (ClueGo) software. miRNAs from PTSD patients were found to be involved in several immunological and biological pathways.
Figure 6 Pathway Analysis depicting a network of dysregulated miRNAs and target genes and their relationship in regulation of immune functions and pathways. A. Dysregulated miRNAs from PTSD patients were found to be involved in immunological pathways when Ingenuity Pathway Analyses were performed. The green tags represent down-regulated miRNAs and red tags up-regulated miRNAs in PBMC from PTSD patients when compared to controls. Circles represent genes, ovals are transcriptional regulators, diamonds are enzymes and triangles are kinases. Solid arrows represent direct action and dashed arrows indirect action. B. Depicts the relationship between miRNAs from PTSD patients with their target genes. First, both upregulated and downregulated miRNAs of PTSD patients were selected following Ingenuity Pathway analysis and then the relationship between miRNAs and genes were analyzed using Cytoscape software. Cytoscape analysis showed relationship between miRNAs and immunological pathways, especially between miRNAs and cytokine-associated genes (IL-1RA, IL-2, IL-2RB, IFN-γ, IL-12, IL-10, IL-17, IL-17R, TGF-β, IL-23A, etc.) playing a role in T cell development and immune functions. The larger circles represent miRNAs that are involved in regulation of a large number of genes, when compared to miRNAs represented by smaller circles. C. Shows the role of dysregulated miRNAs from PTSD patients in various immunological mechanisms and pathways. Upregulated and down-regulated miRNAs from PTSD patients were analyzed using Cytoscape (ClueGo) software. miRNAs from PTSD patients were found to be involved in several immunological and biological pathways.CC0 · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 47 references

Research works printed but not linked: 1

  1. Mardia KV, Kent JT, Bibby JM (1979) Multivariate analysis Academic Press, London.

Cited by

See all 171

Metadata

Authors
Zhou, J., Nagarkatti, P., Zhong, Y., Ginsberg, J. P., Singh, N. P., Zhang, J., & Nagarkatti, M.
Affiliations
  • University of South Carolina (US)
  • Wm. Jennings Bryan Dorn VA Medical Center (US)
Corresponding author
Nagarkatti, Mitzi
Venue
PLoS ONE
Published
2014-04-23
Volume
9
Issue
4
Pages
e94075
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1988757263
Cited by
171
References
46
Citations by year
2026: 6 · 2025: 14 · 2024: 12 · 2023: 15 · 2022: 21 · 2021: 18 · 2020: 15 · 2019: 14 · 2018: 19 · 2017: 15 · 2016: 11 · 2015: 8 · 2014: 3
FWCI
14.55
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, public-domain)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, public-domain)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • U.S. Department of Veterans Affairs (I01 BX001357)
  • National Institutes of Health (BX001357)
  • National Institute of Mental Health (R01MH094755)
  • National Institute of General Medical Sciences (P20GM103641)
  • National Institute of Environmental Health Sciences (R01ES019313)
  • National Center for Complementary and Integrative Health (P01AT003961, R01AT006888)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
post-traumatic stress disorder, combat veterans, microRNA expression, immune dysregulation, peripheral blood mononuclear cells, Th1 cells, Th17 cells, regulatory T cells, Th2 cells, interferon-gamma, IL-17, miR-125a, inflammatory cytokines, epigenetic biomarkers
MeSH terms
Becaplermin, Adult, Humans, Interferon-gamma, Leukocytes, Mononuclear, Male, Middle Aged, Stress Disorders, Post-Traumatic, Veterans, Interleukin-4, Chemokine CCL5, Interleukin-17, Proto-Oncogene Proteins c-sis, MicroRNAs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dysregulation in microRNA Expression Is Associated with Alterations in Immune Functions in Combat Veterans with Post-Traumatic Stress Disorder. https://app.cochat.ai/papers/10.1371/journal.pone.0094075
The paper
Zhou, J., Nagarkatti, P., Zhong, Y., Ginsberg, J. P., Singh, N. P., Zhang, J., & Nagarkatti, M. (2014). Dysregulation in microRNA Expression Is Associated with Alterations in Immune Functions in Combat Veterans with Post-Traumatic Stress Disorder. PLoS ONE. https://doi.org/10.1371/journal.pone.0094075

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.